Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion
NASDAQ:MOVE

Movano 5/19/2026 Earnings Report

Movano logo
$24.46 +0.57 (+2.39%)
Closing price 05/21/2026 04:00 PM Eastern
Extended Trading
$24.62 +0.16 (+0.67%)
As of 05/21/2026 07:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

Movano EPS Results

Actual EPS
-$3.13
Consensus EPS
-$2.65
Beat/Miss
Missed by -$0.48
One Year Ago EPS
N/A

Movano Revenue Results

Actual Revenue
$0.51 million
Expected Revenue
$7.63 million
Beat/Miss
Missed by -$7.12 million
YoY Revenue Growth
N/A

Movano Announcement Details

Quarter
Date
5/19/2026
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Movano Earnings Headlines

Creo Medical Moves to Sell 49% Stake in European Subsidiary to Local CEO
 |  tipranks.comhttps://www.tipranks.com/news/company-announcements/creo-medical-moves-to-sell-49-stake-in-european-subsidiary-to-local-ceo?utm_source=marketbeat.com&utm_medium=referral
Aspen Moves to Correct Record on Batu Kawan Industrial Park 2 Bid
 |  tipranks.comhttps://www.tipranks.com/news/company-announcements/aspen-moves-to-correct-record-on-batu-kawan-industrial-park-2-bid?utm_source=marketbeat.com&utm_medium=referral
A 17-year investing experiment investigated in Dublin
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
 |  Porter & Company (Ad)
Ethereum Price Eyes Breakout Move, Traders Watch Key Resistance Closely
 |  newsbtc.comhttps://www.newsbtc.com/analysis/eth/ethereum-price-eyes-breakout-2150/
Insider Shake-Up: Key Renasant Director Unloads Stake in Surprise Move
 |  tipranks.comhttps://www.tipranks.com/news/insider-trading/insider-shake-up-key-renasant-director-unloads-stake-in-surprise-move-insider-trading-news?utm_source=marketbeat.com&utm_medium=referral
Horizon Kinetics Director Quietly Boosts Stake in Strategic Insider Move
 |  tipranks.comhttps://www.tipranks.com/news/insider-trading/horizon-kinetics-director-quietly-boosts-stake-in-strategic-insider-move-insider-trading-news?utm_source=marketbeat.com&utm_medium=referral
See More Movano Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Movano? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Movano and other key companies, straight to your email.

About Movano

Movano (NASDAQ:MOVE) Health, Inc. (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality. The ring communicates wirelessly with a companion mobile application, where users can view detailed daily reports, set personalized health goals, and share data securely with healthcare providers or loved ones. By combining hardware design with cloud-based analytics, Movano aims to deliver actionable insights that support preventive care and early intervention.

To advance its platform, Movano collaborates with academic institutions, clinical researchers and technology partners. These collaborations help validate sensor accuracy, refine algorithms and explore new applications in areas such as women’s health, chronic disease management and fitness optimization. The company’s development roadmap includes pursuing regulatory clearances and expanding integrations with electronic health record systems.

Led by a management team with combined expertise in medical devices, consumer electronics and software development, Movano serves customers primarily in North America and is exploring opportunities for expansion into international markets. The company continues to invest in research and development to enhance its sensor suite and broaden its suite of health-monitoring solutions for both consumers and healthcare professionals.

View Movano Profile
Earnings Tools